Atcoflox Tablets 250mg
Couldn't load pickup availability
You can promote by sharing on social networks on the links.
Product Description
Product Name: Atcoflox Tablets 250mg
Product Form: Tablets
Pack Size: 10's
Manufactured By: Acto Pharmaceuticals
Used For:
Ciprofloxacin, the antibiotic component in Atcoflox 250mg tablets, is commonly used to treat bacterial infections such as urinary tract infections, respiratory tract infections, skin infections, and gastrointestinal infections. The additional component may suggest that this medication is used for treating respiratory tract infections associated with cough, but without more information, it's difficult to confirm.
Side Effects:
Side effects of ciprofloxacin may include:
- Nausea or vomiting
- Diarrhea
- Dizziness
- Headache
- Insomnia
- Rash
- Joint or muscle pain
- Tendon rupture (rare but serious)
The side effects associated with the additional component, such as a cough suppressant, would depend on its specific nature.
Precautions:
Precautions for Atcoflox 250mg tablets may include:
- Taking the medication exactly as prescribed by your doctor.
- Completing the full course of treatment, even if you start to feel better before finishing the medication.
- Informing your doctor about any other medications you are taking, including over-the-counter drugs and supplements.
- Avoiding activities that require mental alertness or coordination if you experience dizziness or lightheadedness while taking ciprofloxacin.
- Drinking plenty of fluids to stay hydrated while taking the medication.
- Avoiding exposure to sunlight or artificial UV rays, as ciprofloxacin can make your skin more sensitive to sunlight.
It's crucial to follow your doctor's instructions and report any side effects or concerns promptly. Additionally, ensure that you understand the full list of ingredients in Atcoflox 250mg tablets and any potential interactions they may have with other medications you are taking. If you have any questions or concerns, consult your healthcare provider or pharmacist for further guidance.